Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Beijing Luzhu Biotechnology Co Market Cap?
Beijing Luzhu Biotechnology CoHKSE:02480 24 Market Cap is HK$2,585.87 Mil as of Jul. 20, 2026. GuruFocus rates HKSE:02480 with a GF Score™ of 24/100. The stock has 3 warning signs investors should review. Among 1,423 Biotechnology companies, Beijing Luzhu Biotechnology Co ranks better than 65.35% on this metric.
Beijing Luzhu Biotechnology Co's quarterly market cap
increased
from Dec. 2024 (HK$4,612.70 Mil) to Jun. 2025 (HK$4,811.40 Mil) but then
declined
from Jun. 2025 (HK$4,811.40 Mil) to Dec. 2025 (HK$4,694.35 Mil).
Beijing Luzhu Biotechnology Co's annual market cap
declined
from Dec. 2023 (HK$6,053.23 Mil) to Dec. 2024 (HK$4,612.70 Mil) but then
increased
from Dec. 2024 (HK$4,612.70 Mil) to Dec. 2025 (HK$4,694.35 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Beijing Luzhu Biotechnology Co's Enterprise Value for Today is HK$2,416.94 Mil.
Beijing Luzhu Biotechnology Co (HKSE:02480) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Beijing Luzhu Biotechnology Co Market Cap Related Terms
Beijing Luzhu Biotechnology Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02480 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Beijing Luzhu Biotechnology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Luzhu Biotechnology Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Luzhu Biotechnology Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Beijing Luzhu Biotechnology Co's Market Cap falls into.
Beijing Luzhu Biotechnology Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Luzhu Biotechnology Co (HKSE:02480) has a Market Cap of HK$2,585.87 Mil as of Jul. 20, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beijing Luzhu Biotechnology Co and its competitors. According to the industry distribution chart, Beijing Luzhu Biotechnology Co ranks #493 out of 1423 companies in the Biotechnology industry, placing it in the top 34.6%.
Is Beijing Luzhu Biotechnology Co's Market Cap too high?
Beijing Luzhu Biotechnology Co's current Market Cap is HK$2,585.87 Mil. Based on the distribution chart, Beijing Luzhu Biotechnology Co ranks #493 out of 1423 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Beijing Luzhu Biotechnology Co has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Beijing Luzhu Biotechnology Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Luzhu Biotechnology Co ranks #493 out of 1423 companies for Market Cap. This puts Beijing Luzhu Biotechnology Co in the upper half of its industry. The industry median Market Cap is 113.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.11, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beijing Luzhu Biotechnology Co and its competitors. For the Biotechnology industry, the median Market Cap is 113.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Luzhu Biotechnology Co's current Market Cap is HK$2,585.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Luzhu Biotechnology Co stock overvalued right now?
Beijing Luzhu Biotechnology Co (HKSE:02480) has a current Market Cap of HK$2,585.87 Mil. The current Market Cap is HK$2,585.87 Mil. Beijing Luzhu Biotechnology Co's overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Beijing Luzhu Biotechnology Co (HKSE:02480), the current Market Cap is HK$2,585.87 Mil as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Beijing Luzhu Biotechnology Co Business Description
Beijing Luzhu Biotechnology Co., Ltd. is a biotechnology company committed to developing human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. The Group's product pipeline consisted of three clinical-stage product candidates, including its Core Product, LZ901, and six pre-clinical-stage product candidates.
24GF Score
Get the complete analysis for HKSE:02480
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02480 has been successfully added to your 
